RECOMBINANT VIRUS EXPRESSING CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF
The present invention relates to a recombinant carcinoembryonic antigen (CEA)/vaccinia virus or other viral vector which expresses GEA on the surface of infected cells and which elicits an immune response in vivo directed against CEA or cells ex- pressing CEA an d a pharmaceutical composition contai...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
07.11.1992
|
Edition | 5 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to a recombinant carcinoembryonic antigen (CEA)/vaccinia virus or other viral vector which expresses GEA on the surface of infected cells and which elicits an immune response in vivo directed against CEA or cells ex- pressing CEA an d a pharmaceutical composition containing same. The inventio n also relates to methods of treating patients con- taining carcinoma cells in which CEA is expressed and methods of stimulating the immune system against CEA.
2102623 9219266 PCTABS00017 The present invention relates to a recombinant carcinoembryonic antigen (CEA)/vaccinia virus or other viral vector which expresses CEA on the surface of infected cells and which elicits an immune response in vivo directed against CEA or cells expressing CEA an d a pharmaceutical composition containing same. The invention also relates to methods of treating patients containing carcinoma cells in which CEA is expressed and methods of stimulating the immune system against CEA. |
---|---|
AbstractList | The present invention relates to a recombinant carcinoembryonic antigen (CEA)/vaccinia virus or other viral vector which expresses GEA on the surface of infected cells and which elicits an immune response in vivo directed against CEA or cells ex- pressing CEA an d a pharmaceutical composition containing same. The inventio n also relates to methods of treating patients con- taining carcinoma cells in which CEA is expressed and methods of stimulating the immune system against CEA.
2102623 9219266 PCTABS00017 The present invention relates to a recombinant carcinoembryonic antigen (CEA)/vaccinia virus or other viral vector which expresses CEA on the surface of infected cells and which elicits an immune response in vivo directed against CEA or cells expressing CEA an d a pharmaceutical composition containing same. The invention also relates to methods of treating patients containing carcinoma cells in which CEA is expressed and methods of stimulating the immune system against CEA. |
Author | SCHLOM, JEFFREY KANTOR, JUDITH |
Author_xml | – fullname: SCHLOM, JEFFREY – fullname: KANTOR, JUDITH |
BookMark | eNqNyr0KwjAUQOEMOvj3DvcFBJuCe3p702RIIkladCpF4iRpob4_ZvABnD44nD3b5DmnHbt5QmcabYWNMGjfB6B7iSFo2wEKj9o6Mo1_OKsRyqU7ssUWDEXl2gBOQh8IoiJPTh7Z9jW913T6eWAgKaI6p2Ue07pMz5TTZ0TBqwu_8lpU9R_LF2zoMHE |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | VIRUS RECOMBINANT EXPRIMANT UN ANTIGENE CARCINO-EMBRYONNAIRE ET METHODES D'UTILISATION |
Edition | 5 |
ExternalDocumentID | CA2102623A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2102623A13 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 30 05:40:32 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2102623A13 |
Notes | Application Number: CA19922102623 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19921107&DB=EPODOC&CC=CA&NR=2102623A1 |
ParticipantIDs | epo_espacenet_CA2102623A1 |
PublicationCentury | 1900 |
PublicationDate | 19921107 |
PublicationDateYYYYMMDD | 1992-11-07 |
PublicationDate_xml | – month: 11 year: 1992 text: 19921107 day: 07 |
PublicationDecade | 1990 |
PublicationYear | 1992 |
RelatedCompanies | UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (THE) |
RelatedCompanies_xml | – name: UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (THE) |
Score | 2.4243894 |
Snippet | The present invention relates to a recombinant carcinoembryonic antigen (CEA)/vaccinia virus or other viral vector which expresses GEA on the surface of... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | RECOMBINANT VIRUS EXPRESSING CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19921107&DB=EPODOC&locale=&CC=CA&NR=2102623A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-L8IgfprShL122HIm2arhWajK4b8zT6NdilG67iv-9r6KYXPSUk4ZE8ePm9j7wXgKfcGCKq5lQvUBfXjcSkemoOE72uVofaaV6YKmIaCtOfGW-L_qIF630ujKoT-qWKI6JEZSjvlbqvtz9OLFe9rdw9p2sc2rx6seVqeZMupswZzXUsPpGuZBpjFrM1EVm1ZYNIb6OhdFRr0XWZfT536qSU7W9E8c7heILEyuoCWkXZgVO2_3itAydhE-_GbiN6u0tAVjEZOoGwRUzmQTSbEr5Q_AvEmDA7YoGQPHSidykCRnBVMOYCW5eEPPalOyXSI7MpJ7HPIy69KyAej5mv49aWBzYsmX04BL2Gdrkpixsgo16BWkBGR3TYRzCmSZrRl16eJf3VAO8uowvdP8nc_jN3B2fqZWrtQR3cQ7v6-CweEH-r9FFx7hukxIIy |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbokb87MHstmjYB3BYzNZ1bMpaMgbBE9mXCZdBZMZ_37cG0Iue2rRN077k9fd-fX2vAA-53kdUzTW1QFtc1RNTU1Ozn6h1tjq0TvPClB7TkJv-VH-ZG_MGLHexMDJP6JdMjogalaG-V_K8Xv9cYrnybeXmMV1i0-rZiy1XybfhYpLOKK5jsbFwBVUotait8MiqmQ0ivY1E6aCHjFAypZlTB6WsfyOKdwKHY5ysrE6hUZRtaNHdx2ttOAq3_m6sblVvcwYoKipCJ-A2j8ksiKYTwuZSfgEfEmpHNOCChU70JnhACY4Khoxj6ZKQxb5wJ0R4ZDphJPZZxIR3DsRjMfVVXNpiL4YFtfeb0C6gWa7K4hLIoFugFZBpA61vIBhrSZppT908S4z3Hp5degc6f05z9U_fPbT8OBwtRgF_vYZj-Uq1vk3t3UCz-vgsbhGLq_ROSvEb36qFHA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=RECOMBINANT+VIRUS+EXPRESSING+CARCINOEMBRYONIC+ANTIGEN+AND+METHODS+OF+USE+THEREOF&rft.inventor=SCHLOM%2C+JEFFREY&rft.inventor=KANTOR%2C+JUDITH&rft.date=1992-11-07&rft.externalDBID=A1&rft.externalDocID=CA2102623A1 |